Overexpression of TBK1 in MHCC97-L and HepG2 cells can significantly downregulate the killing effect of these drugs on HCC cells, and the IC50 values of the drugs on the cells were significantly increased (Table 4 and Table 5). The gene discussed is TBK1; the disease is hepatocellular carcinoma.